Open AccessJournal Article
The UNOS Scientific Renal Transplant Registry.
Cecka Jm,Paul I. Terasaki +1 more
Reads0
Chats0
TLDR
Based upon data reported to the UNOS Scientific Renal Transplant Registry regarding transplants performed between 1994-1998, the one- and 3-year graft survival rates for 16,288 recipients of living donor kidneys were 93% and 86%, respectively, with a half-life of 17 years.Abstract:
Based upon data reported to the UNOS Scientific Renal Transplant Registry regarding transplants performed between 1994-1998, the one- and 3-year graft survival rates for 16,288 recipients of living donor kidneys were 93% and 86%, respectively, with a half-life of 17 years Among those were 2,129 transplants from HLA-identical siblings with one- and 3-year graft survival rates of 96% and 93% and a 39-year half-life, 3,140 sibling donor grafts matched for one HLA haplotype with 94% and 87% one- and 3-year survival rates and a 16-year half-life and 2,071 transplants from living unrelated donors with 92% and 86% one- and 3-year graft survival rates and a 17-year half-life The overall results of 35,289 cadaver donor kidney transplants were 87% and 76% graft survival at one- and 3-years with a 10-year half-life There was a 13% difference in 3-year graft survival rates when recipients of kidneys from donors over or under age 55 were considered separately and the half-life was 11 years for younger donors and 6 years when the donor was older (p < 0001) A total of 4,688 (14%) of cadaver kidney recipients received an HLA-matched transplant Their graft survival rates were 89% and 83% at one and 3 years and their graft half-life was 16 years compared with 86% and 76% one- and 3-year graft survival and a 10-year half-life for recipients of HLA-mismatched kidneys (p < 0001) The recipient's age affected both graft survival and the cause of graft loss Recipients aged 19-45 had a 78% 3-year graft survival rate compared with 72% for recipients over age 60 or under 18 (p < 0001) However, 65% of graft losses after the first year among older recipients were due to death with a functioning graft compared with 18% among 19-45-year olds Acute rejections accounted for 16% of graft failures after the first year when the recipient was aged 6-18 Immune failures decreased with increasing recipient age The recipient's race also influenced graft survival rates Asian recipients of cadaver kidneys had the highest graft survival rates of 91% and 85% at one and 3 years with a half-life of 18 years The result for Whites and Blacks were significantly lower (87-86% at one year and 78% and 70% at 3 years, respectively; p < 0001) The graft half-life was 12 years for Whites and 7 years for Blacks DGF and acute rejection episodes during the early posttransplant period reduced 3-year survival of cadaveric transplants by 20% and reduced graft half-lives by 2 years (rejections) or 4 years (DGF) When rejections occurred in recipients with DGF, 3-year graft survival was 64% Induction therapy with anti-T-cell reagents did not affect graft survival rates among patients with DGF, but reduced the incidence of early rejections from 27-14% Rejections that occurred within the first 6 months had a more pronounced effect on subsequent graft half-lives (116 years without and 76 years with; p < 001) and increased the proportion of kidneys that failed because of chronic rejection from 31-43% between 1-3 years More than 50% of diabetics received a simultaneous pancreas kidney transplant during this period and the graft and patient survival rates were significantly higher for recipients of the SPK transplants When deaths with a functioning graft were censored, however, the graft failure rates were not significantly different The major causes of death among cadaver kidney transplant recipients were cardiovascular (26%) and infections (24%) during the first posttransplant year Between 1-3 years, the percentage of deaths due to infection fell to 15% and malignancies accounted for 13% of patient deathsread more
Citations
More filters
Journal ArticleDOI
External validation of a proposed prognostic model for the prediction of 1-year postoperative eGFR after living donor nephrectomy
Ulf Kulik,Jill Gwiasda,Felix Oldhafer,Alexander Kaltenborn,Viktor Arelin,Faikah Gueler,Nicolas Richter,Juergen Klempnauer,Harald Schrem +8 more
TL;DR: The proposed prognostic model for the prediction of postoperative eGFR was successfully validated in this cohort and is considered as generally applicable.
Journal ArticleDOI
Intraoperative biomarkers in renal transplantation.
Laura-Nanna Lohkamp,Laura-Nanna Lohkamp,Robert Öllinger,Antonios Chatzigeorgiou,Ben Min-Woo Illigens,Ben Min-Woo Illigens,Timo Siepmann,Timo Siepmann +7 more
TL;DR: This review summarizes the current literature on the value of IRI biomarkers in outcome prediction following renal transplantation as well their capacity as surrogate end points from an intraoperative perspective.
Journal ArticleDOI
Preservation of renal function during maintenance therapy with cyclosporine.
Daniel Serón,Francesc Moreso +1 more
TL;DR: The efficacy of C2 monitoring during the maintenance period must be assessed not only by means of evaluation of renal function, but also histologic assessment using protocol biopsies, particularly the therapeutic range for C2 levels in patients receiving different immunosuppressive combinations.
Journal ArticleDOI
The role of medications and their management in acute kidney injury.
TL;DR: Renal recovery from drug-induced AKI begins once the offending agent has been removed, if clinically possible, and is complete in most cases, although it is uncommon that renal replacement therapy will be needed while recovery occurs.
Journal ArticleDOI
Kidney transplantation: Charles Nicolle Hospital experience.
R. Bardi,M. Cherif,R. Goucha,Mondher Ounissi,Ezzedine Abderrahim,F. Ben Hamida,Mouna Makhlouf,S. Jendoubi-Ayed,Th. Ben Romdhane,S. Ben Boujemaa,F. El Younsi,K. Ayed,H. Ben Maiz,A. Kheder,Yousr Gorgi,T. Ben Abdallah +15 more
TL;DR: The results were comparable to experienced centers, however, the member of kidney transplantations does not match the increased number of patients on renal replacement therapy, and it is advisable to promote obtaining organs from brain-dead donors.
Related Papers (5)
The Banff 97 working classification of renal allograft pathology
Lorraine C. Racusen,Kim Solez,Robert B. Colvin,Stephen M. Bonsib,Maria Castro,Tito Cavallo,Byron P. Croker,A. Jake Demetris,Cynthia B. Drachenberg,Agnes B. Fogo,Peter N. Furness,Lillian W. Gaber,Ian W. Gibson,Dennis Glotz,J. Goldberg,Joseph P. Grande,Philip F. Halloran,H.E. Hansen,Barry Hartley,Pekka Hayry,Claire M. Hill,Ernesto O. Hoffman,Lawrence G. Hunsicker,Anne S. Lindblad,Niels Marcussen,M. J. Mihatsch,Tibor Nadasdy,Peter Nickerson,T. Steen Olsen,John C. Papadimitriou,Parmjeet Randhawa,David C. Rayner,Ian S.D. Roberts,Stephen Rose,D. Rush,Luis Salinas-Madrigal,Daniel R. Salomon,Stale Sund,Eero Taskinen,Kiril Trpkov,Yutaka Yamaguchi +40 more